Nrx Pharmaceuticals Inc 's Revenue in the fiscal year 2025 $ 1.23 millions
Nrx Pharmaceuticals Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Nrx Pharmaceuticals Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Nrx Pharmaceuticals Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Nrx Pharmaceuticals Inc 's Revenue in the fiscal year 2021 $ -1.69 millions
NRXP Revenue third quarter 2026 Y/Y Growth Comment
Nrx Pharmaceuticals Inc achieved in the third quarter 2026, above Company average Revenue surge of 882.92% year on year, to $ 2.36 millions.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 74 other companies have achieved higher Revenue growth. While Nrx Pharmaceuticals Inc ' s Revenue doubling of 882.92% ranks overall at the positon no. 1380 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Nrx Pharmaceuticals Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
306.2 %
24.11 %
-100 %
(Dec 31 2025)
NRXP's III. Quarter Q/Q Revenue Comment
Nrx Pharmaceuticals Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 114.45%, to $ 2.36 millions, from $1.10 millions in the second quarter. NRXP is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 74 other companies have achieved higher Revenue quarter on quarter growth. While Nrx Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1380.
Nrx Pharmaceuticals Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 114.45%, to $ 2.36 millions, from $1.10 millions in the second quarter. NRXP is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 74 other companies have achieved higher Revenue quarter on quarter growth. While Nrx Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 1380.
Nrx Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year
Nrx Pharmaceuticals Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 882.92% year on year, to $ 6 millions if the fiscal year would have ended in Sep 30 2026. Nrx Pharmaceuticals Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2026. And, Nrx Pharmaceuticals Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Jun 30 2026 rise was beneth at 62.37 % from $3.39 millions achieved in the period from Jun 30 2026 to Sep 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%.
Nrx Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Nrx Pharmaceuticals Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 882.92% year on year, to $ 6 millions if the fiscal year would have ended in Sep 30 2026. Nrx Pharmaceuticals Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Jun 30 2026. And, Nrx Pharmaceuticals Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Jun 30 2026 rise was beneth at 62.37 % from $3.39 millions achieved in the period from Jun 30 2026 to Sep 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%. The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 62.37 % increase from $3.39 millions in the period from Jun 30 2026 to Sep 30 2025.
Nrx Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Nrx Pharmaceuticals Inc Revenue Growth Rates (NRXP), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.